SciClone Pharmaceuticals Inc. (NASDAQ:SCLN) shares traded down 3.2% during mid-day trading on Thursday . The company traded as low as $10.31 and last traded at $10.36, with a volume of 264,129 shares trading hands. The stock had previously closed at $10.70.

The stock’s 50-day moving average price is $12.15 and its 200 day moving average price is $11.38. The company has a market capitalization of $523.55 million and a price-to-earnings ratio of 19.43.

SciClone Pharmaceuticals (NASDAQ:SCLN) last released its earnings results on Tuesday, May 10th. The specialty pharmaceutical company reported $0.19 EPS for the quarter. The business had revenue of $36.50 million for the quarter, compared to the consensus estimate of $33.60 million. On average, equities analysts forecast that SciClone Pharmaceuticals Inc. will post $0.33 EPS for the current fiscal year.

An institutional investor recently bought a new position in SciClone Pharmaceuticals stock. Matarin Capital Management LLC bought a new position in shares of SciClone Pharmaceuticals Inc. (NASDAQ:SCLN) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor bought 173,899 shares of the specialty pharmaceutical company’s stock, valued at approximately $1,600,000. Matarin Capital Management LLC owned 0.35% of SciClone Pharmaceuticals as of its most recent SEC filing.

SciClone Pharmaceuticals, Inc is a pharmaceutical company. The Company’s product portfolio of therapies includes oncology, infectious diseases and cardiovascular disorders. The Company operates in two segments: China and the Rest of the World, including its operations in the United States and Hong Kong.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.